Covid: Merck’s oral pill shows promise against hospitalisation, death
Washington : Merck on Friday announced its anti-viral drug has shown "compelling results" in clinical trials -- halving the risk of hospitalisation or death for patients with mild or moderate cases of Covid.Molnupiravir, co-developed with…